Rapid Communication |
From UCLA Departments of Pathology (P.T.S., J.A.B.) and Medicine (P.T.S., M.-L.B., D.K.V., M.C.T., A.J.L., J.A.B.), Los Angeles, Calif; Cytel Corporation (D.S., M.J.E.), San Diego, Calif.
Correspondence to Peggy Shih, Department of Pathology and Laboratory Medicine, UCLA School of Medicine, Center for the Health Sciences, 10833 Le Conte Ave, Los Angeles, CA 90095-1732.
AbstractAtherosclerotic lesion
development is characterized by the recruitment of leukocytes,
principally monocytes, to the vessel wall. Considerable interest has
been focused on the adhesion molecule(s) involved in
leukocyte/endothelial interactions. The goal of the
present study was to determine the role of the very late antigen-4
(VLA-4) integrin/ligand interaction in fatty streak development using
murine models. Because
4 null mice are not viable, a peptidomimetic
was used to block VLA-4mediated leukocyte binding. The ability of a
synthetic peptidomimetic of connecting segment-1 (CS-1 peptide) to
block the recruitment of leukocytes and the accumulation of lipid in
the aortic sinus of either wild-type mice (strain C57BL/6J) or mice
with a low-density lipoprotein null mutation (LDLR-/-) maintained on
an atherogenic diet was assessed. The active (Ac) CS-1 peptide or
scrambled (Sc) CS-1 peptide was delivered subcutaneously into mice
using a mini osmotic pump. Mice were exposed to the peptide for 24 to
36 hours before the onset of the atherogenic diet. In C57BL/6J mice,
leukocyte entry into the aortic sinus, as assessed by en face
preparations, was inhibited by the active peptide (Ac=28±4, Sc=54±6
monocytes/valve; P=0.004). Additionally, frozen sections
stained with Oil Red O were analyzed to assess lipid
accumulation in the aortic sinus. C57BL/6J mice that received the (Ac)
compound demonstrated significantly reduced lesion areas as compared
with mice that received the (Sc) peptide (Ac=4887±4438
µm2, Sc=15 009 ±5619 µm2;
P<0.0001). In a separate study, LDLR-/- mice were
implanted with pumps containing either the (Ac) or (Sc) peptide before
initiation of the atherogenic diet. Because LDLR-/- mice fed a chow
diet displayed small lesions at 14 weeks, the effects of the peptide
seen in these animals represented a change in early lipid
accumulation rather than initiation. By using whole-mount preparations,
the (Ac) but not the (Sc) peptide significantly reduced the area of
lipid accumulation in the aortic sinus, resulting in an approximate
66% decrease. Plasma analysis from all studies revealed
concentrations of peptide to be present at levels previously
determined by in vitro analysis to block adhesion. (Ac) CS-1
peptide, which blocks VLA-4 on the leukocyte surface, is effective in
reducing leukocyte recruitment and lipid accumulation in the aortic
sinus. The present study provides in vivo evidence that the VLA-4
integrin plays an important role in the initiation of the
atherosclerotic lesion and lipid accumulation, and it suggests a
potential therapeutic strategy for this disease.
Key Words: atherosclerosis monocyte connecting segment-1 fibronectin
4ß1
This article has been cited by other articles:
![]() |
E. J.A. van Wanrooij, P. de Vos, M. G. Bixel, D. Vestweber, T. J.C. van Berkel, and J. Kuiper Vaccination against CD99 inhibits atherogenesis in low-density lipoprotein receptor-deficient mice Cardiovasc Res, June 1, 2008; 78(3): 590 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Riou, B. Mees, B. Esposito, R. Merval, J. Vilar, D. Stengel, E. Ninio, R. van Haperen, R. de Crom, A. Tedgui, et al. High Pressure Promotes Monocyte Adhesion to the Vascular Wall Circ. Res., April 27, 2007; 100(8): 1226 - 1233. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Mukherjee, A. K. Mishra, S. Mukhopadhyay, and J. R. Hoidal High Concentration of Antioxidants N-Acetylcysteine and Mitoquinone-Q Induces Intercellular Adhesion Molecule 1 and Oxidative Stress by Increasing Intracellular Glutathione J. Immunol., February 1, 2007; 178(3): 1835 - 1844. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Schapira, E. Lutgens, A. de Fougerolles, A. Sprague, A. Roemen, H. Gardner, V. Koteliansky, M. Daemen, and S. Heeneman Genetic Deletion or Antibody Blockade of {alpha}1{beta}1 Integrin Induces a Stable Plaque Phenotype in ApoE-/- Mice Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): 1917 - 1924. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Hannah, P. Skehel, M. Erent, L. Knipe, D. Ogden, and T. Carter Differential Kinetics of Cell Surface Loss of von Willebrand Factor and Its Propolypeptide after Secretion from Weibel-Palade Bodies in Living Human Endothelial Cells J. Biol. Chem., June 17, 2005; 280(24): 22827 - 22830. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Motivala, A. Sarfatti, L. Olmos, and M. R. Irwin Inflammatory Markers and Sleep Disturbance in Major Depression Psychosom Med, March 1, 2005; 67(2): 187 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Furnkranz, A. Schober, V. N. Bochkov, P. Bashtrykov, G. Kronke, A. Kadl, B. R. Binder, C. Weber, and N. Leitinger Oxidized Phospholipids Trigger Atherogenic Inflammation in Murine Arteries Arterioscler. Thromb. Vasc. Biol., March 1, 2005; 25(3): 633 - 638. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Andres Atherogenic role of the type EIIIA fibronectin domain Blood, July 1, 2004; 104(1): 3 - 4. [Full Text] [PDF] |
||||
![]() |
M. H. Tan, Z. Sun, S. L. Opitz, T. E. Schmidt, J. H. Peters, and E. L. George Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis Blood, July 1, 2004; 104(1): 11 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ma and E. R. O'Brien Antagonism of the {alpha}4 integrin subunit attenuates the acute inflammatory response to stent implantation yet is insufficient to prevent late intimal formation J. Leukoc. Biol., June 1, 2004; 75(6): 1016 - 1021. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. OSTERUD and E. BJORKLID Role of Monocytes in Atherogenesis Physiol Rev, October 1, 2003; 83(4): 1069 - 1112. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Cole, G. Subbanagounder, S. Mukhopadhyay, J. A. Berliner, and D. K. Vora Oxidized Phospholipid-Induced Endothelial Cell/Monocyte Interaction Is Mediated by a cAMP-Dependent R-Ras/PI3-Kinase Pathway Arterioscler. Thromb. Vasc. Biol., August 1, 2003; 23(8): 1384 - 1390. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Huber, H. Boechzelt, B. Karten, M. Surboeck, V. N. Bochkov, B. R. Binder, W. Sattler, and N. Leitinger Oxidized Cholesteryl Linoleates Stimulate Endothelial Cells to Bind Monocytes via the Extracellular Signal-Regulated Kinase 1/2 Pathway Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 581 - 586. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Methia, P. Andre, C. V. Denis, M. Economopoulos, and D. D. Wagner Localized reduction of atherosclerosis in von Willebrand factor-deficient mice Blood, September 1, 2001; 98(5): 1424 - 1428. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yoshida, T. Sawada, H. Ishii, R. E. Gerszten, A. Rosenzweig, M. A. Gimbrone Jr, Y. Yasukochi, and F. Numano HMG-CoA Reductase Inhibitor Modulates Monocyte-Endothelial Cell Interaction Under Physiological Flow Conditions In Vitro : Involvement of Rho GTPase-Dependent Mechanism Arterioscler. Thromb. Vasc. Biol., July 1, 2001; 21(7): 1165 - 1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Huo, A. Hafezi-Moghadam, and K. Ley Role of Vascular Cell Adhesion Molecule-1 and Fibronectin Connecting Segment-1 in Monocyte Rolling and Adhesion on Early Atherosclerotic Lesions Circ. Res., July 21, 2000; 87(2): 153 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Subbanagounder, N. Leitinger, P. T. Shih, K. F. Faull, and J. A. Berliner Evidence That Phospholipid Oxidation Products and/or Platelet-Activating Factor Play an Important Role in Early Atherogenesis : In Vitro and In Vivo Inhibition by WEB 2086 Circ. Res., August 20, 1999; 85(4): 311 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Huber, H. Boechzelt, B. Karten, M. Surboeck, V. N. Bochkov, B. R. Binder, W. Sattler, and N. Leitinger Oxidized Cholesteryl Linoleates Stimulate Endothelial Cells to Bind Monocytes via the Extracellular Signal-Regulated Kinase 1/2 Pathway Arterioscler. Thromb. Vasc. Biol., April 1, 2002; 22(4): 581 - 586. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |